Finally, analysis of molecular signatures revealed that BC grade remains an independent risk factor in multivariate models and provides additional information to improve BC subtyping beyond endocrine status and HER2 overexpression [11, 12]. This evidence concerns the gene ERBB2 and breast cancer.